This study showed a significant difference in clinical prognosis between the epilepsy caused by ATP6V0C mutations and Dravet syndrome caused by SCN1A mutations. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.